Achieve Life Sciences (ACHV) Reports In-Line Q4 EPS

Achieve Life Sciences (NASDAQ: ACHV) reported Q4 EPS of ($0.28), in-line with the analyst estimate of ($0.28).

For earnings history and earnings-related data on Achieve Life Sciences (ACHV) click here.

You May Also Be Interested In

• Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
• SEACOR Marine acknowledges letter from shareholder Pointillist
• Keurig Dr Pepper coffee chief to depart ahead of planned split